Navigation Links
Johns Hopkins School of Medicine postdoctoral fellows win awards
Date:2/9/2011

Nine Johns Hopkins University School of Medicine postdoctoral fellows recently were awarded fellowships. Rita Strack, Ph.D., received one of 12 total Damon Runyon Cancer Research Foundation fellowships, and Bagrat Abazyan, M.D., Robert H. Cudmore, Ph.D., Mi-Hyeon Jang, Ph.D., Shinichi Kano, Sun-Hong Kim, Ph.D., M.D., Ph.D., Minae Niwa, Ph.D., Frederick Charles Nucifora Jr., Ph.D., D.O., M.H.S., and Emily G. Severance, Ph.D., were among the 214 recipients of the NARSAD: The Brain and Behavior Research Fund Young Investigator fellowship.

The Damon Runyon Cancer Research Foundation, a nonprofit organization focused on supporting innovative early career researchers, encourages the nation's most promising young scientists to pursue careers in cancer research by providing them with independent funding ($156,000 over three years) to work on innovative projects. Rita L. Strack, Ph.D., a postdoc in molecular biology and genetics, is studying how cells ensure quality control during protein synthesis. The quality control process, called nonsense-mediated decay, is essential for cells to function properly; synthesizing defective proteins can lead to many types of cancer. This process may be a novel target for cancer diagnosis or therapeutics.

Since 1987, NARSAD: The Brain and Behavior Research Fund has awarded more than $274 million in 4,046 grants to 3,319 scientists around the world. Receiving up to $60,000 over two years, the fellowship recipients pursue brain and behavior research related to schizophrenia, depression, bipolar disorder, autism, ADHD and anxiety disorders, such as OCD and PTSD.

Robert H. Cudmore, Ph.D., a postdoctoral fellow in neuroscience, is studying on the cellular level the effects of exercise as an alternative and complementary treatment for mood disorders. Minae Niwa, Ph.D., of of psychiatry and behavioral sciences, is studying how the immune system affects functioning of the dopamine neurotransmitter system to induce psychiatric disorders. Frederick Charles Nucifora Jr., Ph.D., D.O., M.H.S., an assistant professor of psychiatry, is exploring the role of a gene called neuronal PAS3 (NPAS3) in schizophrenia. Bagrat Abazyan, M.D., a fellow in psychiatry and behavioral sciences, is generating a mouse model of a gene that when functioning abnormally in brain cells may contribute to symptoms of schizophrenia. Mi-Hyeon Jang, Ph.D., a postdoctoral fellow in neurology, is exploring how new cells are born in the hippocampal region of the brain and how this is affected by the so-called disrupted-in-schizophrenia-1 (DISC1) gene. Shinichi Kano, M.D., Ph.D., of psychiatry and behavioral sciences, is investigating a mechanism through which altered glial cells and infection may work synergistically to contribute to schizophrenia. Sun-Hong Kim, Ph.D., a postdoctoral fellow in psychiatry and behavioral sciences, is studying a new mediator of nitric oxide-regulated behaviors in relation to brain development disturbances implicated in schizophrenia. Emily G. Severance, Ph.D., a research associate in pediatrics, is testing whether a breached gastrointestinal barrier contributes to symptoms of psychiatric disorders.


'/>"/>

Contact: Audrey Huang
audrey@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
Source:Eurekalert

Related medicine news :

1. Jimmy Johnson Will Step Into Role as Honorary Crew Chief for ExtenZe Racing at Daytona
2. Protecting patients: Study shows that Johns Hopkins flu vaccination rates twice national average
3. Longtime Quality Assurance Executive Randy Johnson Joins White Pine Systems as Vice President of Product Services
4. Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing
5. AADR awards the 2010 Jack Hein Public Service Award to David C. Johnsen
6. Johnson & Johnson to Participate in RBC Capital Markets Health Care Conference
7. Robert Wood Johnson Foundation Launches New Scholars, Fellows & Leadership Programs Web Site
8. Johns Hopkins Launches “Energy Policy and Climate” Master's Degree
9. SC Johnson and Bill & Melinda Gates Foundation Unite to Combat Malaria
10. Johns Hopkins Health System Acquires Imorgon Ultrasound PACS Product
11. Cancer research award to Johns Hopkins basic scientist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... ... Bellus Medical, a leader in medical aesthetics, recently acquired ... photodynamic cosmetics (PDC). , Allumera® is the first PDC cream specifically formulated to ... minimize the appearance of pores – all with minimal downtime and results that ...
(Date:4/25/2017)... ... ... A stressful work environment can hurt the physical and emotional health of employees. ... workplace. The goal of Clearview Resolution Services has always been to help others, starting ... will be shutting down the office early on Fridays. The Clearview team will use ...
(Date:4/25/2017)... Lutz, FL (PRWEB) , ... April 25, 2017 , ... ... transform their smiles by using Invisalign® in Lutz, FL. With the help ... oral health and aesthetics with fewer potential complications, more discretion and less pain. ...
(Date:4/25/2017)... ... ... Back Pain Centers of America (BPC), which connects people searching ... area, announces the launch of a new and proprietary customer relationship management (CRM) system ... physicians to help them with back or neck pain and helps to match them ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Emergency Physician ... book of the Outlier Leadership Series, Outliers in Writing, set to publish in summer ... of Emergency Medicine at the University of Arizona College of Medicine. He also serves ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Inc ., a digital health company focused on modernizing and ... $25 million in Series B funding led by Qiming US ... Seattle that is part of a broader family ... included participation from SR One , who led ZappRx,s ... Google Ventures). As part of the financing, Mark McDade ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... YORK , April 19, 2017 The Mobile ... to showcase a healthy CAGR during the forecast period ... type in the global digital mobile X-Ray devices market, which ... Mn in 2017, expanding at a CAGR of 7% over ... absolute $ opportunity of more than US$ 100 Mn in ...
Breaking Medicine Technology: